Safarol indications
Oral
Cough suppression
Adult: For dry non-productive cough: As 50 mg tab: 2 or 3 tabs 8-12 hrly. As 7.5 mg/5 mL syr: 15 mL 4 times daily.
Child: As 50 mg tab:
Safarol description
Each sustained-release film-coated tablet contains 50 mg of Safarol. Each teaspoonful (5 mL) syrup contains 7.5 mg of Safarol.
Safarol dosage
The maximum duration of treatment without doctor's prescription is one week.
Tablet: Adolescents Over 12 Years of Age: 1 or 2 tablets daily.
Adults: 2 or 3 tablets daily at 8 or 12 hour intervals. To be swallowed whole.
Syrup: Children 3 to 6 Years of Age: One teaspoonful (5 mL) 3 times daily.
Children 6 to 12 Years of Age: Two (2) teaspoonfuls (10 mL) 3 times daily.
Adolescents Over 12 Years of Age: One tablespoonful (15 mL) 3 times daily.
Adults: 15 mL 4 times daily.
Wash and dry the graduated cup after each use and between different users.
Safarol interactions
Sulphinpyrazone, a drug used as an antithrombotic agent and inhibitor of platelet aggregation has a potent side effect as a uricosuric agent. The uricosuric side effect increases the urinary excretion of uric acid effectively blocking hepatic conjugation. Tests show that Sulphinpyrazone’s effect on Safarol is a reduction of liver function to 60% of normal without interfering with protein binding. Taking alpha-lipoic acid or chromium with tolbutamide may require a change in the drugs dosage. Use ephedra with caution when taking tolbutamide; ephedra can raise blood sugar levels.
Safarol side effects
Adverse reactions are listed by system organ class and frequency. Frequencies are defined as: Very common (=1/10); common (=1/100 to <1/10); uncommon (=1/1,000 to <1/100); rare (=1/10,000 to <1/1,000); very rare (<1/10,000), or not known (cannot to be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Nervous System Disorders: Rare: Somnolence.
Gastrointestinal Disorders: Rare: Nausea, diarrhea.
Skin and Subcutaneous Tissue Disorders: Rare: Urticaria.
Safarol contraindications
You should not take tolbutamide if you have had an allergic reaction to it. Safarol should not be taken if you are suffering from diabetic ketoacidosis (a life-threatening medical emergency caused by insufficient insulin and marked by excessive thirst, nausea, fatigue, pain below the breastbone, and fruity breath). In addition, Safarol should not be used as the sole therapy in treating type 1 (insulin-dependent) diabetes.
Active ingredient matches for Safarol:
Butamirate in Greece.
Butamirate citrate in Greece.
List of Safarol substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Rondover (Greece) | |
| Safarol Medichrom (Greece) | |
| Sinakof (Bangladesh) | |
| Sinecod (Bahrain, Bangladesh, Belgium, Bulgaria, Croatia (Hrvatska), Czech Republic, Egypt, Georgia, Greece, Hungary, Iraq, Italy, Jordan, Kuwait, Latvia, Lebanon, Luxembourg, Malta, Oman, Peru, Poland, Portugal, Qatar, Romania, Russian Federation, Saudi Arabia, Slovakia, Slovenia, Switzerland, Thailand, Turkey, United Arab Emirates, Yemen) | |
| Drops; Oral; Butamirate Citrate 5 mg / ml (Zyma) | |
| Syrup; Oral; Butamirate Citrate 7.5 mg / 5 ml (Zyma) | |
| Tablet; Oral; Butamirate Citrate 50 mg (Zyma) | |
| Sinecod 0.15%/200ml - 1 Syrup (Zyma) | $ 24.00 |
| Sinecod 7.5 mg/5 mL x 1 Bottle 200 mL (Zyma) | |
| Sinecod 5 mg/1 mL x 1 Bottle 20 mL (Zyma) | |
| Sinecod 50 mg x 10 Tablet (Zyma) | |
| Sinecod 4 mg/5 mL x 60 mL (Zyma) | |
| Sinecod 4 mg/5 mL x 120 mL (Zyma) | |
| Sinecod 50 mg x 1 Box 10 Tablet (Zyma) | |
| Sinecod 0.15% (Belgium, Cyprus, Luxembourg) | |
| Sinecod 1.5mg/ml (Oman) | |
| Sinecod 50 mg retard (Hungary) | |
| Sinecod 5mg/ml (Oman) | |
| Sinecod depo (Turkey) | |
| Sinecod Forte (Philippines) | |
| Sinecod Forte 50 mg x 48's (Novartis Healthcare) | |
| Sinecod Forte 50 mg x 100's (Novartis Healthcare) | $ 27.35 |
| Sinecod Forte 7.5 mg/5 mL x 60 mL (Novartis Healthcare) | $ 2.10 |
| Sinecod Forte 7.5 mg/5 mL x 120 mL (Novartis Healthcare) | $ 3.46 |
| Sinecod Forte SR tab 50 mg 100's (Novartis Healthcare) | $ 27.35 |
| Sinecod Forte syr 7.5 mg/5 mL 60 mL x 1's (Novartis Healthcare) | $ 2.10 |
| Sinecod Forte syr 7.5 mg/5 mL 120 mL x 1's (Novartis Healthcare) | $ 3.46 |
| Sinecod Kinder (Switzerland) | |
| Sinecod SYR (Greece) | |
| Sinecod Tosse Sedativo (Italy) | |
| Sinetus (Serbia) | |
| Sintuss (Bulgaria) | |
| Siroflex (Greece) | |
| Solmirat (Turkey) | |
| Stilex (Greece) | |
| Gel; Topical; Lidocaine Hydrochloride 1.5%; Pyrilamine Maleate 1.5%; Vitamin B5 / Dexpanthenol 5% (Farmanic) | |
| Spray; Topical; Lidocaine Hydrochloride 1.5%; Pyrilamine Maleate 1.5%; Vitamin B5 / Dexpanthenol 5% (Farmanic) | |
| Supremin (Croatia (Hrvatska), Poland) | |
| Supremin 15 mg x 10's (Pliva krakow) | $ 0.68 |
| Supremin 30 mg x 10's (Pliva krakow) | $ 0.99 |
| Sutussi (Taiwan) | |
| Sutussi 0.8 mg/1 mL x 1 mL | |
| Sutussi 0.8 mg/1 mL x 60 mL | |
| Sutussi 0.8 mg/1 mL x 120 mL | |
| Sutussi 0.8 mg/1 mL x 200 mL | |
| Swidro Hustensirup mit Butamirat (Switzerland) | |
| Talasa (Argentina) | |
See 169 substitutes for Safarol | |
Reviews
The results of a survey conducted on ndrugs.com for Safarol are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Safarol. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet1 consumer reported age
| Users | % | ||
|---|---|---|---|
| > 60 | 1 | 100.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
